On October 21, Novo Nordisk announced positive news on the cardiovascular benefits of its oral GLP-1R agonist, Rybelsus, ...

The SOUL cardiovascular outcomes trial was a double-blinded, randomised trial that compared oral semaglutide to placebo as an ...

Novo expects to file for a label expansion for Rybelsus in the United States and the European Union around the turn of the ...

RANCHO CORDOVA, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- iMD Companies, Inc. (OTC: ICBU) subsidiary Riize, LLC (Riize Health ...

Novo Nordisk and Eli Lilly still have first-mover advantage, but Roche, Pfizer and others all have similar products in the ...

Amgen's move follows the lifting of a temporary injunction on the launch of its Pavblu-branded biosimilar by the US Court of ...

Yet another therapy with FDA accelerated approval suffers a setback; Sage’s tough year continues; Sanofi drops $326 million ...

ROSEMONT, Ill., Oct. 23, 2024 /PRNewswire/ -- According to a new national survey released today by the Society for Vascular Surgery (SVS), nearly one in three Americans at the highest risk for ...

Sleep apnea is a common sleep disorder that affects more than 20 percent of people in the United States. It happens when your ...

Kamala Harris is not offering sweeping change, even as voters express dissatisfaction about the direction of the country. She’s an institutionalist who wants to preserve democratic ideals, and ...

With millions of U.S. voters already heading to the polls, Democratic presidential candidateKamala Harris on Wednesday will seek support from undecided voters at a televised town hall in ...

Gisèle Pelicot’s ex-husband, Dominique Pelicot, is accused of inviting strangers to sexually assault her while she was drugged and unconscious. The trial has transformed how France discusses ...